Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1078939

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1078939

High Potency APIs Market/HPAPI Market by Type(Innovative, Generic), Type of Synthesis(Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers(Captive, Merchant), Application(Oncology, Hormonal Imbalance, Glaucoma) Region -Global forecast -2027

PUBLISHED:
PAGES: 270 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

The HPAPI market is projected to reach USD 39.6 Billion by 2027 from USD 24.5 billion in 2022, at a CAGR of 10.1% from 2022 to 2027. The market is driven by increasing demand for oncology drugs, growing demand for antibody-drug conjugates and others.

"The innovative HPAPIs segment is expected to account for the largest share of the market in 2021"

Based on type, the HPAPI market is segmented into innovative and generic. The innovative segment is expected to account for the largest share of the HPAPI market in 2021. The large share can be attributed to the increased R&D investments.

"The Synthetic APIs segment to account for the largest share of the market in 2021"

Based on type of synthesis, the market is segmented into synthetic and biotech HPAPIs. The synthetic APIs segment is expected to command the largest share in 2021. Ease of production and emergence of new molecules and technological advancements in synthesis are driving growth of synthetic HPAPI segment.

"The Oncology segment is expected to account for the largest share of the market in 2021"

Based on therapeutica application, the market is divided into oncology, hormonal imbalance, glaucoma, and other therapeutic applications. In 2021, Oncology segment is expected to account for the largest share in the market. The launch of new target therapies in addition to technological advancements and growing prevalence of cancer across the globe are driving growth of oncology segment.

"The Asia region is the fastest growing region of HPAPI market from 2022 to 2027"

HPAPI market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). Asia to grow at the highest CAGR during the forecast period. High prevalence of chronic diseases, lifestyle diseases, age related diseases and government efforts for encouragement for the adoption of generics are some of the factors driving the growth of the market in Asia.

Breakdown of primaries

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:

- By Respondent: Supply Side: 70%, Demand Side: 30%

- By Designation: Managers: 65%, Executives: 25%, and CXOs: 10%

- By Region: North America: 25%, Europe: 20%, Asia: 45%, and RoW: 10%

Prominent players in the HPAPI market include Pfizer, Inc. (US), F. Hoffmann-La Roche (Switzerland), Sanofi (France), Bristol-Myers Squibb Company (US), Bayer AG (Germany), Novartis International AG (Switzerland), Boehringer Ingelheim International GmbH. (Germany), Teva Pharmaceutical Industries Ltd. (Israel), Eli Lilly and Company (US), Merck & Co., Inc. (US), AbbVie (US), and Viatris Inc. (US).

Research Coverage:

The report segments the HPAPI market based on region (Asia, Europe, North America, and RoW), Type (Innovative, Generic), Type of Synthesis (Biotech, Synthetic), Type of manufacturer (Captive and Merchant), Therapeutic Applications (Oncology, Hormonal Imbalance, Glaucoma). The report also provides a comprehensive review of market drivers, opportunities, restraints, and challenges in the HPAPI market.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants in this market and provide information on the closest approximations of the revenue numbers for the overall HPAPI market and its subsegments. This report will help the stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and provide information on key market drivers, restraints, opportunities, and challenges.

Product Code: PH 4897

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED
    • FIGURE 1 HPAPI MARKET: GEOGRAPHIC SCOPE
    • 1.3.2 YEARS CONSIDERED
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 SUMMARY OF CHANGES
  • 1.7 STAKEHOLDERS

2 RESEARCH METHODOLOGY

    • FIGURE 2 RESEARCH DESIGN
  • 2.1 SECONDARY DATA
    • 2.1.1 SECONDARY SOURCES
  • 2.2 PRIMARY DATA
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: HPAPI MARKET
    • 2.2.1 KEY DATA FROM PRIMARY SOURCES
    • 2.2.2 PRIMARY INSIGHTS
  • 2.3 MARKET SIZE ESTIMATION
    • FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
    • FIGURE 5 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • 2.4 MARKET GROWTH RATE PROJECTIONS
    • FIGURE 6 HPAPI MARKET: CAGR PROJECTIONS
  • 2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 7 DATA TRIANGULATION
  • 2.6 RESEARCH ASSUMPTIONS
  • 2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

    • FIGURE 8 HPAPI MARKET, BY TYPE, 2021 VS. 2027
    • FIGURE 9 HPAPI MARKET, BY TYPE OF MANUFACTURER, 2021 VS. 2027
    • FIGURE 10 HPAPI MARKET, BY TYPE OF SYNTHESIS, 2021 VS. 2027
    • FIGURE 11 HPAPI MARKET, BY THERAPEUTIC APPLICATION, 2021 VS. 2027
    • FIGURE 12 GEOGRAPHIC SNAPSHOT OF HPAPI MARKET (2022-2027)

4 PREMIUM INSIGHTS

  • 4.1 HPAPI: MARKET OVERVIEW
    • FIGURE 13 INCREASING DEMAND FOR ONCOLOGY DRUGS AND ANTIBODY-DRUG CONJUGATES TO DRIVE MARKET GROWTH
  • 4.2 HPAPI MARKET, BY TYPE, (2021 VS. 2027)
    • FIGURE 14 INNOVATIVE HPAPIS TO DOMINATE THE GLOBAL MARKET IN 2027
  • 4.3 HPAPI MARKET, BY TYPE OF SYNTHESIS, (2021 VS. 2027)
    • FIGURE 15 SYNTHETIC HPAPIS TO DOMINATE MARKET SHARE IN 2021
  • 4.4 HPAPI MARKET BY THERAPEUTIC AREA (2021-2027)
    • FIGURE 16 ONCOLOGY SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • 4.5 GEOGRAPHICAL SNAPSHOT OF HPAPI MARKET
    • FIGURE 17 CHINA & INDIA TO REGISTER HIGH GROWTH RATES DURING 2022-2027

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 18 HPPAI MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing demand for oncology drugs
    • TABLE 1 PIPELINE OF ONCOLOGY DRUGS (2021)
      • 5.2.1.2 Growing demand for antibody-drug conjugates
      • 5.2.1.3 Increasing focus of leading pharmaceutical companies on HPAPIs
      • 5.2.1.4 Advancements in HPAPI manufacturing technologies
      • 5.2.1.5 Growing focus on precision medicine
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Increasing requirement of large investments for employee safety
      • 5.2.2.2 Discrepancies in HPAPI banding systems
      • 5.2.2.3 Rising number of uncertainties associated with products
      • 5.2.2.4 High risk of cross-contamination
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing opportunities for CMOs and CDMOs
      • 5.2.3.2 Increasing opportunities for companies in emerging markets
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Need for appropriate process designs
      • 5.2.4.2 Constant evolution of industry standards and technologies
  • 5.3 IMPACT OF COVID-19 ON HPAPI MARKET
  • 5.4 REGULATORY ANALYSIS
    • 5.4.1 HANDLING HPAPI
    • 5.4.2 THIRD PARTY CERTIFICATION
    • 5.4.3 CONTAINMENT STRATEGIES
    • 5.4.4 CHALLENGES
  • 5.5 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 2 HPAPI MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.5.1 THREAT OF NEW ENTRANTS
    • 5.5.2 THREAT OF SUBSTITUTES
    • 5.5.3 BARGAINING POWER OF SUPPLIERS
    • 5.5.4 BARGAINING POWER OF BUYERS
    • 5.5.5 DEGREE OF COMPETITION
  • 5.6 TECHNOLOGY ANALYSIS
    • 5.6.1 HANDLING POTENT COMPOUNDS
    • 5.6.2 CONTROLS
    • 5.6.3 SAFETY ASSESSMENT AND STANDARD OPERATING PROCEDURES
    • 5.6.4 DEDICATED EQUIPMENT AND SYSTEMS
    • 5.6.5 EXPERTISE AND TRAINING
    • 5.6.6 COMBUSTIBLE DUST HANDLING
    • 5.6.7 SUITABLE PERSONAL PROTECTIVE EQUIPMENT

6 HPAPI CLASSIFICATION AND OVERVIEW

  • 6.1 INTRODUCTION
  • 6.2 HPAPI INGREDIENTS CLASSIFICATION AS PER SAFEBRIDGE CONSULTANTS
    • TABLE 3 CATEGORIES OF HPAPIS
    • TABLE 4 POTENCY CLASSIFICATION SYSTEM

7 HPAPI MARKET, BY TYPE

  • 7.1 INTRODUCTION
    • FIGURE 19 INNOVATIVE HPAPIS SEGMENT TO DOMINATE HPAPI MARKET
    • TABLE 5 HPAPI MARKET, BY TYPE, 2020-2027 (USD MILLION)
  • 7.2 INNOVATIVE HPAPIS
    • TABLE 6 INNOVATIVE HPAPIS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 7 NORTH AMERICA: INNOVATIVE HPAPIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 8 EUROPE: INNOVATIVE HPAPIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 9 ASIA: INNOVATIVE HPAPIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 7.3 GENERIC HPAPIS
    • TABLE 10 GENERIC HPAPIS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 11 NORTH AMERICA: GENERIC HPAPIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 12 EUROPE: GENERIC HPAPIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 13 ASIA: GENERIC HPAPIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)

8 HPAPI MARKET, BY TYPE OF SYNTHESIS

  • 8.1 INTRODUCTION
    • FIGURE 20 SYNTHETIC SEGMENT TO DOMINATE MARKET IN 2021
    • TABLE 14 HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION)
  • 8.2 SYNTHETIC APIS
    • TABLE 15 SYNTHETIC APIS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 16 NORTH AMERICA: SYNTHETIC APIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 17 EUROPE: SYNTHETIC APIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 18 ASIA: SYNTHETIC APIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 8.2.1 SYNTHETIC APIS MARKET, BY TYPE
    • TABLE 19 SYNTHETIC APIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 20 INNOVATIVE SYNTHETIC APIS
    • TABLE 21 INNOVATIVE SYNTHETIC APIS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 22 NORTH AMERICA: INNOVATIVE SYNTHETIC APIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 23 EUROPE: INNOVATIVE SYNTHETIC APIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 24 ASIA: INNOVATIVE SYNTHETIC APIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 8.2.2 GENERIC SYNTHETIC APIS
    • TABLE 25 GENERIC SYNTHETIC APIS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 26 NORTH AMERICA: GENERIC SYNTHETIC APIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 27 EUROPE: GENERIC SYNTHETIC APIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 28 ASIA: GENERIC SYNTHETIC APIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 8.3 BIOTECH APIS
    • TABLE 29 BIOTECH APIS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 30 NORTH AMERICA: BIOTECH APIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 31 EUROPE: BIOTECH APIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 32 ASIA: BIOTECH APIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 8.3.1 BIOTECH APIS MARKET, BY TYPE
    • TABLE 33 BIOTECH APIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 8.3.2 INNOVATIVE BIOTECH APIS
    • TABLE 34 INNOVATIVE BIOTECH APIS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 35 NORTH AMERICA: INNOVATIVE BIOTECH APIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 36 EUROPE: INNOVATIVE BIOTECH APIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 37 ASIA: INNOVATIVE BIOTECH APIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 8.3.3 BIOSIMILARS
    • TABLE 38 BIOSIMILARS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 39 NORTH AMERICA: BIOSIMILARS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 40 EUROPE: BIOSIMILARS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 41 ASIA: BIOSIMILARS INGREDIENTS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 8.3.4 BIOTECH APIS MARKET, BY PRODUCT
    • TABLE 42 BIOTECH APIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • 8.3.5 MONOCLONAL ANTIBODIES
    • TABLE 43 MONOCLONAL ANTIBODIES MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 8.3.6 VACCINES
    • TABLE 44 VACCINES MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 8.3.7 RECOMBINANT PROTEINS
    • TABLE 45 RECOMBINANT PROTEINS MARKET, BY REGION, 2020-2027 (USD MILLION)

9 HPAPI MARKET, BY TYPE OF MANUFACTURER

  • 9.1 INTRODUCTION
    • FIGURE 21 CAPTIVE HPAPI MANUFACTURERS SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2021
    • TABLE 46 HPAPI MARKET, BY TYPE OF MANUFACTURER, 2020-2027 (USD MILLION)
  • 9.2 CAPTIVE API MANUFACTURERS
    • TABLE 47 CAPTIVE API MANUFACTURERS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 48 NORTH AMERICA: CAPTIVE API MANUFACTURERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 49 EUROPE: CAPTIVE API MANUFACTURERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 50 ASIA: CAPTIVE API MANUFACTURERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 9.3 MERCHANT API MANUFACTURERS
    • TABLE 51 MERCHANT API MANUFACTURERS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 52 NORTH AMERICA: MERCHANT API MANUFACTURERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 53 EUROPE: MERCHANT API MANUFACTURERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 54 ASIA: MERCHANT API MANUFACTURERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 9.3.1 MERCHANT API MANUFACTURERS MARKET BY TYPE
    • TABLE 55 MERCHANT API MANUFACTURERS MARKET BY TYPE, 2020-2027 , (USD MILLION)
    • 9.3.2 INNOVATIVE MERCHANT API MANUFACTURERS
    • TABLE 56 INNOVATIVE MERCHANT API MANUFACTURERS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 57 NORTH AMERICA: INNOVATIVE MERCHANT API MANUFACTURERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 58 EUROPE: INNOVATIVE MERCHANT API MANUFACTURERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 59 ASIA: INNOVATIVE MERCHANT API MANUFACTURERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 9.3.3 GENERIC MERCHANT API MANUFACTURERS
    • TABLE 60 GENERIC MERCHANT API MANUFACTURERS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 61 NORTH AMERICA: GENERIC MERCHANT API MANUFACTURERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 62 EUROPE: GENERIC MERCHANT API MANUFACTURERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 63 ASIA: GENERIC MERCHANT API MANUFACTURERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 9.3.4 MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS
    • TABLE 64 MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020-2027 , (USD MILLION)
    • 9.3.5 SYNTHETIC API MANUFACTURERS
    • TABLE 65 SYNTHETIC API MANUFACTURERS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 66 NORTH AMERICA: SYNTHETIC API MANUFACTURERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 67 EUROPE: SYNTHETIC API MANUFACTURERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 68 ASIA: SYNTHETIC API MANUFACTURERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 9.3.6 BIOTECH API MANUFACTURERS
    • TABLE 69 BIOTECH API MANUFACTURERS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 70 NORTH AMERICA: BIOTECH API MANUFACTURERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 71 EUROPE: BIOTECH API MANUFACTURERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 72 ASIA: BIOTECH API MANUFACTURERS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)

10 HPAPI MARKET, BY THERAPEUTIC APPLICATION

  • 10.1 INTRODUCTION
    • FIGURE 22 ONCOLOGY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
    • TABLE 73 HPAPI MARKET, BY THERAPEUTIC APPLICATION, 2020-2027 (USD MILLION)
  • 10.2 ONCOLOGY
    • TABLE 74 HPAPI MARKET FOR ONCOLOGY, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 75 NORTH AMERICA: HPAPI MARKET FOR ONCOLOGY, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 76 EUROPE: HPAPI MARKET FOR ONCOLOGY, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 77 ASIA: HPAPI MARKET FOR ONCOLOGY, BY COUNTRY, 2020-2027 (USD MILLION)
  • 10.3 HORMONAL IMBALANCE
    • TABLE 78 HPAPI MARKET FOR HORMONAL IMBALANCE, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 79 NORTH AMERICA: HPAPI MARKET FOR HORMONAL IMBALANCE, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 80 EUROPE: HPAPI MARKET FOR HORMONAL IMBALANCE, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 81 ASIA: HPAPI MARKET FOR HORMONAL IMBALANCE, BY COUNTRY, 2020-2027 (USD MILLION)
  • 10.4 GLAUCOMA
    • TABLE 82 HPAPI MARKET FOR GLAUCOMA, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 83 NORTH AMERICA: HPAPI MARKET FOR GLAUCOMA, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 84 EUROPE: HPAPI MARKET FOR GLAUCOMA, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 85 ASIA: HPAPI MARKET FOR GLAUCOMA, BY COUNTRY, 2020-2027 (USD MILLION)
  • 10.5 OTHER THERAPEUTIC APPLICATIONS
    • TABLE 86 HPAPI MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 87 NORTH AMERICA: HPAPI MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 88 EUROPE: HPAPI MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 89 ASIA: HPAPI MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)

11 HPAPI MARKET, BY REGION

  • 11.1 INTRODUCTION
    • TABLE 90 HPAPI MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 11.2 NORTH AMERICA
    • FIGURE 23 NORTH AMERICA: HPAPI MARKET SNAPSHOT
    • TABLE 91 NORTH AMERICA: HPAPI MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 92 NORTH AMERICA: HPAPI MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 93 NORTH AMERICA: HPAPI MARKET, BY TYPE OF MANUFACTURER, 2020-2027 (USD MILLION)
    • TABLE 94 NORTH AMERICA: MERCHANT APIS MANUFACTURERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 95 NORTH AMERICA: MERCHANT APIS MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION)
    • TABLE 96 NORTH AMERICA: HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION)
    • TABLE 97 NORTH AMERICA: SYNTHETIC APIS INGREDIENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 98 NORTH AMERICA: BIOTECH APIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 99 NORTH AMERICA: BIOTECH HPAPI MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 100 NORTH AMERICA: HPAPI MARKET, BY THERAPEUTIC APPLICATION, 2020-2027 (USD MILLION)
    • 11.2.1 US
      • 11.2.1.1 Increasing Investments in cancer research to drive market growth
    • TABLE 101 US: HPAPI MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 102 US: HPAPI MARKET, BY TYPE OF MANUFACTURER, 2020-2027 (USD MILLION)
    • TABLE 103 US: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 104 US: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION)
    • TABLE 105 US: HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION)
    • TABLE 106 US: SYNTHETIC APIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 107 US: BIOTECH APIS MARKET, BY TYPE, 2020-2027 (USD MILLION
    • TABLE 108 US: BIOTECH APIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 109 US: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2020-2027 (USD MILLION)
    • 11.2.2 CANADA
      • 11.2.2.1 The rising prevalence of cancer to drive market growth
    • TABLE 110 CANADA: HPAPI MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 111 CANADA: HPAPI MARKET, BY TYPE OF MANUFACTURER, 2020-2027 (USD MILLION)
    • TABLE 112 CANADA: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 113 CANADA: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION)
    • TABLE 114 CANADA: HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION)
    • TABLE 115 CANADA: SYNTHETIC APIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 116 CANADA: BIOTECH APIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 117 CANADA: BIOTECH APIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 118 CANADA: HPAPI MARKET, BY THERAPEUTIC APPLICATION, 2020-2027 (USD MILLION)
  • 11.3 EUROPE
    • FIGURE 24 EUROPE: HPAPI MARKET SNAPSHOT
    • TABLE 119 EUROPE: HPAPI MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 120 EUROPE: HPAPI MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 121 EUROPE: HPAPI MARKET, BY TYPE OF MANUFACTURER, 2020-2027 (USD MILLION)
    • TABLE 122 EUROPE: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 123 EUROPE: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION)
    • TABLE 124 EUROPE: HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION)
    • TABLE 125 EUROPE: SYNTHETIC APIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 126 EUROPE: BIOTECH APIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 127 EUROPE: BIOTECH APIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 128 EUROPE: HPAPI MARKET, BY THERAPEUTIC APPLICATION, 2020-2027 (USD MILLION)
    • 11.3.1 GERMANY
      • 11.3.1.1 The strong focus on biotech and medical research to drive market growth
    • TABLE 129 GERMANY: HPAPI MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 130 GERMANY: HPAPI MARKET, BY TYPE OF MANUFACTURER, 2020-2027 (USD MILLION)
    • TABLE 131 GERMANY: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 132 GERMANY: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION)
    • TABLE 133 GERMANY: HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION)
    • TABLE 134 GERMANY: SYNTHETIC APIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 135 GERMANY: BIOTECH APIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 136 GERMANY: BIOTECH APIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 137 GERMANY: HPAPI MARKET, BY THERAPEUTIC APPLICATION, 2020-2027 (USD MILLION)
    • 11.3.2 FRANCE
      • 11.3.2.1 The presence of many pharmaceutical companies coupled with the growing demand for novel cancer therapies to drive market growth
    • TABLE 138 FRANCE: HPAPI MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 139 FRANCE: HPAPI MARKET, BY TYPE OF MANUFACTURER, 2020-2027 (USD MILLION)
    • TABLE 140 FRANCE: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 141 FRANCE: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION)
    • TABLE 142 FRANCE: HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION)
    • TABLE 143 FRANCE: SYNTHETIC APIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 144 FRANCE: BIOTECH APIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 145 FRANCE: BIOTECH APIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 146 FRANCE: HPAPI MARKET, BY THERAPEUTIC APPLICATION, 2020-2027 (USD MILLION)
    • 11.3.3 UK
      • 11.3.3.1 Increasing in the demand for cancer therapies to drive market growth
    • TABLE 147 UK: HPAPI MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 148 UK: HPAPI MARKET, BY TYPE OF MANUFACTURER, 2020-2027 (USD MILLION)
    • TABLE 149 UK: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 150 UK: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION)
    • TABLE 151 UK: HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION)
    • TABLE 152 UK: SYNTHETIC APIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 153 UK: BIOTECH APIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 154 UK: BIOTECH APIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 155 UK: HPAPI MARKET, BY THERAPEUTIC APPLICATION, 2020-2027 (USD MILLION)
    • 11.3.4 ITALY
      • 11.3.4.1 Robust generic API production capacities to drive the market growth
    • TABLE 156 ITALY: HPAPI MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 157 ITALY: HPAPI MARKET, BY TYPE OF MANUFACTURER, 2020-2027 (USD MILLION)
    • TABLE 158 ITALY: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 159 ITALY: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION)
    • TABLE 160 ITALY: HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION)
    • TABLE 161 ITALY: SYNTHETIC APIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 162 ITALY: BIOTECH APIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 163 ITALY: BIOTECH APIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 164 ITALY: HPAPI MARKET, BY THERAPEUTIC APPLICATION, 2020-2027 (USD MILLION)
    • 11.3.5 SPAIN
      • 11.3.5.1 Developments in the ADC segment to drive market growth
    • TABLE 165 SPAIN: HPAPI MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 166 SPAIN: HPAPI MARKET, BY TYPE OF MANUFACTURER, 2020-2027 (USD MILLION)
    • TABLE 167 SPAIN: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 168 SPAIN: MERCHANT MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION)
    • TABLE 169 SPAIN: HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION)
    • TABLE 170 SPAIN: SYNTHETIC APIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 171 SPAIN: BIOTECH APIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 172 SPAIN: BIOTECH APIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 173 SPAIN: HPAPI MARKET, BY THERAPEUTIC APPLICATION, 2020-2027 (USD MILLION)
    • 11.3.6 REST OF EUROPE
    • TABLE 174 REST OF EUROPE: HPAPI MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 175 REST OF EUROPE: HPAPI MARKET, BY TYPE OF MANUFACTURER, 2020-2027 (USD MILLION)
    • TABLE 176 REST OF EUROPE: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 177 REST OF EUROPE: MERCHANT MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION)
    • TABLE 178 REST OF EUROPE: HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION)
    • TABLE 179 REST OF EUROPE: SYNTHETIC APIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 180 REST OF EUROPE: BIOTECH APIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 181 REST OF EUROPE: BIOTECH APIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 182 REST OF EUROPE: HPAPI MARKET, BY THERAPEUTIC APPLICATION, 2020-2027 (USD MILLION)
  • 11.4 ASIA
    • FIGURE 25 ASIA: HPAPI MARKET SNAPSHOT
    • TABLE 183 ASIA: HPAPI MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 184 ASIA: HPAPI MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 185 ASIA: HPAPI MARKET, BY TYPE OF MANUFACTURER, 2020-2027 (USD MILLION)
    • TABLE 186 ASIA: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 187 ASIA: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION)
    • TABLE 188 ASIA: HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION)
    • TABLE 189 ASIA: SYNTHETIC APIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 190 ASIA: BIOTECH APIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 191 ASIA: BIOTECH APIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 192 ASIA: HPAPI MARKET, BY THERAPEUTIC APPLICATION, 2020-2027 (USD MILLION)
    • 11.4.1 JAPAN
      • 11.4.1.1 Investments in the development of ADC products to drive market growth
    • TABLE 193 JAPAN: HPAPI MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 194 JAPAN: HPAPI MARKET, BY TYPE OF MANUFACTURER, 2020-2027 (USD MILLION)
    • TABLE 195 JAPAN: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 196 JAPAN: MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION)
    • TABLE 197 JAPAN: HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION)
    • TABLE 198 JAPAN: SYNTHETIC APIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 199 JAPAN: BIOTECH APIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 200 JAPAN: BIOTECH APIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 201 JAPAN: HPAPI MARKET, BY THERAPEUTIC APPLICATION, 2020-2027 (USD MILLION)
    • 11.4.2 CHINA
      • 11.4.2.1 Low labor costs, presence of well-equipped manufacturing plants to drive market growth
    • TABLE 202 CHINA: HPAPI MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 203 CHINA: HPAPI MARKET, BY TYPE OF MANUFACTURER, 2020-2027 (USD MILLION)
    • TABLE 204 CHINA: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 205 CHINA: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION)
    • TABLE 206 CHINA: HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION)
    • TABLE 207 CHINA: SYNTHETIC APIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 208 CHINA: BIOTECH APIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 209 CHINA: BIOTECH APIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 210 CHINA: HPAPI MARKET, BY THERAPEUTIC APPLICATION, 2020-2027 (USD MILLION)
    • 11.4.3 INDIA
      • 11.4.3.1 Increasing Investments in Oncology to drive market growth
    • TABLE 211 INDIA: HPAPI MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 212 INDIA: HPAPI MARKET, BY TYPE OF MANUFACTURER, 2020-2027 (USD MILLION)
    • TABLE 213 INDIA: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 214 INDIA: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION)
    • TABLE 215 INDIA: HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION)
    • TABLE 216 INDIA: SYNTHETIC APIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 217 INDIA: BIOTECH APIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 218 INDIA: BIOTECH APIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 219 INDIA: HPAPI MARKET, BY THERAPEUTIC APPLICATION, 2020-2027 (USD MILLION)
    • 11.4.4 REST OF ASIA
    • TABLE 220 REST OF ASIA: HPAPI MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 221 REST OF ASIA: HPAPI MARKET, BY TYPE OF MANUFACTURER, 2020-2027 (USD MILLION)
    • TABLE 222 REST OF ASIA: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 223 REST OF ASIA: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION)
    • TABLE 224 REST OF ASIA: HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION)
    • TABLE 225 REST OF ASIA: SYNTHETIC APIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 226 REST OF ASIA: BIOTECH APIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 227 REST OF ASIA: BIOTECH APIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 228 REST OF ASIA: HPAPI MARKET, BY THERAPEUTIC APPLICATION, 2020-2027 (USD MILLION)
  • 11.5 REST OF THE WORLD
    • FIGURE 26 REST OF THE WORLD: HPAPI MARKET SNAPSHOT
    • TABLE 229 ROW: HPAPI MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 230 ROW: HPAPI MARKET, BY TYPE OF MANUFACTURER, 2020-2027 (USD MILLION)
    • TABLE 231 ROW: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 232 ROW: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION)
    • TABLE 233 ROW: HPAPI MARKET, BY TYPE OF SYNTHESIS, 2020-2027 (USD MILLION)
    • TABLE 234 ROW: SYNTHETIC APIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 235 ROW: BIOTECH APIS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 236 ROW: BIOTECH APIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 237 ROW: HPAPI MARKET, BY THERAPEUTIC APPLICATION, 2020-2027 (USD MILLION)

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
  • 12.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN
    • FIGURE 27 KEY DEVELOPMENTS IN HPAPI MARKET, 2019-2022
  • 12.3 MARKET SHARE ANALYSIS
    • FIGURE 28 HPAPI MARKET: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2021
    • TABLE 238 HPAPI MARKET: DEGREE OF COMPETITION
  • 12.4 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
    • FIGURE 29 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN HPAPI MARKET, 2019-2021
  • 12.5 COMPANY EVALUATION QUADRANT
    • 12.5.1 STARS
    • 12.5.2 EMERGING LEADERS
    • 12.5.3 PERVASIVE PLAYERS
    • FIGURE 30 HPAPI MARKET: COMPANY EVALUATION QUADRANT
  • 12.6 FOOTPRINT OF COMPANIES
    • TABLE 239 PORTFOLIO ANALYSIS BY TYPE OF SYNTHESIS: HPAPI MARKET (2021)
    • TABLE 240 PORTFOLIO ANALYSIS BY TYPE OF MANUFACTURER: HPAPI MARKET (2021)
    • TABLE 241 PORTFOLIO ANALYSIS BY TYPE OF THERAPEUTIC APPLICATIONS: HPAPI MARKET (2021)
  • 12.7 REGIONAL FOOTPRINT
    • TABLE 242 REGIONAL FOOTPRINT OF COMPANIES: HPAPI MARKET (2021)
  • 12.8 COMPETITIVE SCENARIO
    • TABLE 243 PRODUCT LAUNCHES
    • TABLE 244 DEALS

13 COMPANY PROFILES

  • 13.1 MAJOR PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 13.1.1 PFIZER INC.
    • TABLE 245 PFIZER INC.: BUSINESS OVERVIEW
    • FIGURE 31 PFIZER INC.: COMPANY SNAPSHOT (2021)
    • 13.1.2 NOVARTIS INTERNATIONAL AG
    • TABLE 246 NOVARTIS INTERNATIONAL AG: BUSINESS OVERVIEW
    • FIGURE 32 NOVARTIS INTERNATIONAL AG: COMPANY SNAPSHOT (2021)
    • 13.1.3 SANOFI
    • TABLE 247 SANOFI: BUSINESS OVERVIEW
    • FIGURE 33 SANOFI: COMPANY SNAPSHOT (2021)
    • 13.1.4 F. HOFFMANN-LA ROCHE
    • TABLE 248 F. HOFFMANN-LA ROCHE: BUSINESS OVERVIEW
    • FIGURE 34 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2021)
    • 13.1.5 BRISTOL-MYERS SQUIBB COMPANY
    • TABLE 249 BRISTOL-MYERS SQUIBB COMPANY: BUSINESS OVERVIEW
    • FIGURE 35 BRISTOL-MYERS SQUIBB COMPANY: COMPANY SNAPSHOT (2021)
    • 13.1.6 BOEHRINGER-INGELHEIM
    • TABLE 250 BOEHRINGER-INGELHEIM: BUSINESS OVERVIEW
    • FIGURE 36 BOEHRINGER-INGELHEIM: COMPANY SNAPSHOT (2021)
    • 13.1.7 TEVA PHARMACEUTICAL INDUSTRY LTD.
    • TABLE 251 TEVA PHARMACEUTICAL INDUSTRY LTD.: BUSINESS OVERVIEW
    • FIGURE 37 TEVA PHARMACEUTICAL INDUSTRY LTD.: COMPANY SNAPSHOT (2021)
    • 13.1.8 ELI LILY AND COMPANY
    • TABLE 252 ELI LILY AND COMPANY: BUSINESS OVERVIEW
    • FIGURE 38 ELI LILY AND COMPANY: COMPANY SNAPSHOT (2021)
    • 13.1.9 MERCK & CO., INC.
    • TABLE 253 MERCK & CO., INC.: BUSINESS OVERVIEW
    • FIGURE 39 MERCK & CO., INC.: COMPANY SNAPSHOT (2021)
    • 13.1.10 ABBVIE INC.
    • TABLE 254 ABBVIE INC.: BUSINESS OVERVIEW
    • FIGURE 40 ABBVIE INC.: COMPANY SNAPSHOT (2021)
    • 13.1.11 VIATRIS INC.
    • TABLE 255 VIATRIS INC.: BUSINESS OVERVIEW
    • FIGURE 41 VIATRIS INC.: COMPANY SNAPSHOT (2021)
    • 13.1.12 BAYER
    • TABLE 256 BAYER AG: BUSINESS OVERVIEW
    • FIGURE 42 BAYER AG: COMPANY SNAPSHOT (2021)
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 AVAILABLE CUSTOMIZATIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!